Dyne Therapeutics, Inc.
z-rostudirsen
Duchenne muscular dystrophy
Date
TBD
Approval decision · Date TBD estimated
What's at stake
A final FDA approval decision on z-rostudirsen for Duchenne muscular dystrophy is expected Date TBD.
Primary source
· SEC 8-K
verified 12h ago
“continue to be driven by our goal to deliver functional improvement for individuals living with DMD. We remain committed to disciplined execution as we advance our two lead programs and broader pipeline and aim to maximize returns for our s”